Achieving High Quality Cancer Survivorship Care
Dr. Sandra Swain discusses the importance of high-quality survivorship care and introduces some of ASCO’s resources to help your oncology practice provide... Learn More
Lilly’s Commitment to Alzheimer’s Disease Research and Development
A message from Lilly’s CEO, Dr. John Lechleiter, on our commitment to Alzheimer’s research and development.
Experts gather to explore response to chronic illness in poor countries
On November 29, global health experts from the Novartis Foundation, Novartis Access, NGOs and academia gathered at our Basel headquarters to discuss... Learn More


